Nicholas S Hendren1,2, James A de Lemos1,2, Colby Ayers1, Sandeep R Das1,2, Anjali Rao1,2, Spencer Carter1,2, Anna Rosenblatt1,2, Jason Walchok3, Wally Omar4, Rohan Khera5,6, Anita A Hegde1,2, Mark H Drazner1, Ian J Neeland7, Justin L Grodin1,2. 1. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (N.S.H., J.A.d.L., C.A., S.R.D., A. Rao, S.C., A. Rosenblatt, A.A.H., M.H.D., J.L.G.). 2. Parkland Health and Hospital System, Dallas, TX (N.S.H., J.A.d.L., S.R.D., A. Rao, S.C., A. Rosenblatt, A.A.H., J.L.G.). 3. American Heart Association, Dallas, TX (J.W.). 4. Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA (W.O.). 5. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT (R.K.). 6. Center for Outcomes Research and Evaluation, Yale New Haven Hospital, CT (R.K.). 7. University Hospitals Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, OH (I.J.N.).
Abstract
BACKGROUND: Obesity may contribute to adverse outcomes in coronavirus disease 2019 (COVID-19). However, studies of large, broadly generalizable patient populations are lacking, and the effect of body mass index (BMI) on COVID-19 outcomes- particularly in younger adults-remains uncertain. METHODS: We analyzed data from patients hospitalized with COVID-19 at 88 US hospitals enrolled in the American Heart Association's COVID-19 Cardiovascular Disease Registry with data collection through July 22, 2020. BMI was stratified by World Health Organization obesity class, with normal weight prespecified as the reference group. RESULTS: Obesity, and, in particular, class III obesity, was overrepresented in the registry in comparison with the US population, with the largest differences among adults ≤50 years. Among 7606 patients, in-hospital death or mechanical ventilation occurred in 2109 (27.7%), in-hospital death in 1302 (17.1%), and mechanical ventilation in 1602 (21.1%). After multivariable adjustment, classes I to III obesity were associated with higher risks of in-hospital death or mechanical ventilation (odds ratio, 1.28 [95% CI, 1.09-1.51], 1.57 [1.29-1.91], 1.80 [1.47-2.20], respectively), and class III obesity was associated with a higher risk of in-hospital death (hazard ratio, 1.26 [95% CI, 1.00-1.58]). Overweight and class I to III obese individuals were at higher risk for mechanical ventilation (odds ratio, 1.28 [95% CI, 1.09-1.51], 1.54 [1.29-1.84], 1.88 [1.52-2.32], and 2.08 [1.68-2.58], respectively). Significant BMI by age interactions were seen for all primary end points (P-interaction<0.05 for each), such that the association of BMI with death or mechanical ventilation was strongest in adults ≤50 years, intermediate in adults 51 to 70 years, and weakest in adults >70 years. Severe obesity (BMI ≥40 kg/m2) was associated with an increased risk of in-hospital death only in those ≤50 years (hazard ratio, 1.36 [1.01-1.84]). In adjusted analyses, higher BMI was associated with dialysis initiation and with venous thromboembolism but not with major adverse cardiac events. CONCLUSIONS: Obese patients are more likely to be hospitalized with COVID-19, and are at higher risk of in-hospital death or mechanical ventilation, in particular, if young (age ≤50 years). Obese patients are also at higher risk for venous thromboembolism and dialysis. These observations support clear public health messaging and rigorous adherence to COVID-19 prevention strategies in all obese individuals regardless of age.
BACKGROUND: Obesity may contribute to adverse outcomes in coronavirus disease 2019 (COVID-19). However, studies of large, broadly generalizable patient populations are lacking, and the effect of body mass index (BMI) on COVID-19 outcomes- particularly in younger adults-remains uncertain. METHODS: We analyzed data from patients hospitalized with COVID-19 at 88 US hospitals enrolled in the American Heart Association's COVID-19Cardiovascular Disease Registry with data collection through July 22, 2020. BMI was stratified by World Health Organization obesity class, with normal weight prespecified as the reference group. RESULTS: Obesity, and, in particular, class III obesity, was overrepresented in the registry in comparison with the US population, with the largest differences among adults ≤50 years. Among 7606 patients, in-hospital death or mechanical ventilation occurred in 2109 (27.7%), in-hospital death in 1302 (17.1%), and mechanical ventilation in 1602 (21.1%). After multivariable adjustment, classes I to III obesity were associated with higher risks of in-hospital death or mechanical ventilation (odds ratio, 1.28 [95% CI, 1.09-1.51], 1.57 [1.29-1.91], 1.80 [1.47-2.20], respectively), and class III obesity was associated with a higher risk of in-hospital death (hazard ratio, 1.26 [95% CI, 1.00-1.58]). Overweight and class I to III obese individuals were at higher risk for mechanical ventilation (odds ratio, 1.28 [95% CI, 1.09-1.51], 1.54 [1.29-1.84], 1.88 [1.52-2.32], and 2.08 [1.68-2.58], respectively). Significant BMI by age interactions were seen for all primary end points (P-interaction<0.05 for each), such that the association of BMI with death or mechanical ventilation was strongest in adults ≤50 years, intermediate in adults 51 to 70 years, and weakest in adults >70 years. Severe obesity (BMI ≥40 kg/m2) was associated with an increased risk of in-hospital death only in those ≤50 years (hazard ratio, 1.36 [1.01-1.84]). In adjusted analyses, higher BMI was associated with dialysis initiation and with venous thromboembolism but not with major adverse cardiac events. CONCLUSIONS: Obese patients are more likely to be hospitalized with COVID-19, and are at higher risk of in-hospital death or mechanical ventilation, in particular, if young (age ≤50 years). Obese patients are also at higher risk for venous thromboembolism and dialysis. These observations support clear public health messaging and rigorous adherence to COVID-19 prevention strategies in all obese individuals regardless of age.
Entities:
Keywords:
COVID-19; body mass index; death; obesity
Authors: Rohan Khera; Bobak J Mortazavi; Benjamin D Pollock; Wade L Schulz; Veer Sangha; Frederick Warner; H Patrick Young; Joseph S Ross; Nilay D Shah; Elitza S Theel; William G Jenkinson; Camille Knepper; Karen Wang; David Peaper; Richard A Martinello; Cynthia A Brandt; Zhenqiu Lin; Albert I Ko; Harlan M Krumholz Journal: medRxiv Date: 2021-05-13
Authors: Neal A Chatterjee; Paul N Jensen; Andrew W Harris; Daniel D Nguyen; Henry D Huang; Richard K Cheng; Jainy J Savla; Timothy R Larsen; Joanne Michelle D Gomez; Jeanne M Du-Fay-de-Lavallaz; Rozenn N Lemaitre; Barbara McKnight; Sina A Gharib; Nona Sotoodehnia Journal: Influenza Other Respir Viruses Date: 2021-05-24 Impact factor: 5.606
Authors: Pratik A Patel; Stacey A Lapp; Gabrielle Grubbs; Venkata V Edara; Christina A Rostad; Claire L Stokes; Melinda G Pauly; Evan J Anderson; Anne Piantadosi; Mehul S Suthar; Surender Khurana; Himalee S Sabnis Journal: Br J Haematol Date: 2021-06-07 Impact factor: 8.615